Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
TRDA
Entrada Therapeutics Focuses on Neuromuscular Disease Treatments
| 2024-08-13 |
PHARMACEUTICAL
Entrada Therapeutics Secures $100M Investment
| 2024-06-24 |
PHARMACEUTICAL
Entrada Therapeutics Focused on EEV Therapeutics for Neuromuscular Diseases
| 2024-03-13 |
PHARMACEUTICAL